Barbara Mason's Tomorrow

Findings of reduced drinking, relapse, and improved mood and sleep with gabapentin in recently abstinent alcoholics by the Mason lab has lead to a pivotal trial in support of FDA approval for a long acting form of gabapentin (gabapentin enacarbil, Horizont) as a new treatment for alcohol use disorder.